Literature DB >> 25800313

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.

L Rebegea, D Firescu, M Dumitru, R Anghel.   

Abstract

BACKGROUND: The arm lymphedema is reported as being the most frequent late reaction and complication that influences breast cancer patients'€™ quality of life after lymph node dissection and radiotherapy. The aim of the study is to identify the risk factors in arm lymphedema occurrence in breast cancer patients who performed radical conservatory surgery, chemotherapy and radiotherapy.
MATERIAL AND METHODS: We analysed 305 breast cancer patients who underwent treatment in the "Sf. Ap. Andrei"€ Emergency Clinical Hospital, Galati, Radiotherapy and Oncology Department, between the 1st of January 2010 and 31st of December 2012. We tried to find the risk factors for arm lymphedema development after treatment of breast cancer: the association of adjuvant radiotherapy with surgery, chemotherapy,hormonal therapy, number of removed lymph nodes,and number of lymph nodes with metastases, the co-morbid illnesses (obesity, diabetes mellitus and high blood pressure).
RESULTS: Our study evidences that the association of adjuvant radiotherapy, including the lymph node regions, with radical or conservatory surgery with lymph node dissection represents a statistically significant risk factor, with relative risk, RR =1.87, 95%C.I.=1.39-€3.51, p<0.001. The number of removed lymph nodes was found to be a risk factor with statistical significance. For more than 25 removed lymph nodes, the relative risk for arm lymphedema development was RR=1.95(95%C.I. =1.79-4.51) and for 16-25 removed lymph nodes the relative risk, RR = 1.78, 95% C.I. = 1.46 - 3.23. Other analysed risk factors, which did not influence lymphedema development, were: associated chemotherapy or hormonal therapy,presence of co-morbid illnesses.
CONCLUSIONS: The development of arm lymphedema is an unpredictable occurrence that can happen years after axillary surgery.Breast and arm oedema continue to be late reactions that can be reduced by use of biopsy sentinel technique with avoiding of axillary lymph node dissection, when the sentinel lymph node is negative, knowing that lymphedema risk after sentinel lymph node is 5% comparative with lymphedema risk after axillary lymph node dissection which is 16%, by avoiding obesity, and performing modern therapy techniques. Celsius.

Entities:  

Mesh:

Year:  2015        PMID: 25800313

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  12 in total

1.  Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.

Authors:  Vishnu Prasad Pulappadi; Shashi Paul; Smriti Hari; Ekta Dhamija; Smita Manchanda; Kamal Kataria; Sandeep Mathur; Kalaivani Mani; Ajay Gogia; Svs Deo
Journal:  Br J Radiol       Date:  2021-09-07       Impact factor: 3.039

2.  Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.

Authors:  Loryn K Bucci; Cheryl L Brunelle; Madison C Bernstein; Amy M Shui; Tessa C Gillespie; Sacha A Roberts; George E Naoum; Alphonse G Taghian
Journal:  Ann Surg Oncol       Date:  2021-06-11       Impact factor: 5.344

3.  Level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy: a retrospective study.

Authors:  R V Bhargavan; A Mirza; K Cherian; J Krishna; P Augustine
Journal:  Ann R Coll Surg Engl       Date:  2019-11-22       Impact factor: 1.891

4.  Lymphoscintigraphy detecting alterations of upper limb lymphatic flow following early sentinel lymph node biopsy in breast cancer.

Authors:  Almir Jose Sarri; Eduardo Tinois da Silva; Rene Aloisio da Costa Vieira; Katia Hiromoto Koga; Pedro Henrique Moriguchi Cação; Vitor Coca Sarri; Sonia Marta Moriguchi
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-04-19

5.  Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer.

Authors:  Almir José Sarri; Rogério Dias; Carla Elaine Laurienzo; Mônica Carboni Pereira Gonçalves; Daniel Spadoto Dias; Sonia Marta Moriguchi
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

6.  Discussion of relationships among changes of pathological indicators, postoperative lymphedema of the upper limb, and prognosis of patients with breast cancer.

Authors:  Xiping Zhang; Binbin Tang; Dehong Zou; Hongjian Yang; Enqi Qiao; Xiangming He; Feijiang Yu
Journal:  Biosci Rep       Date:  2019-04-16       Impact factor: 3.840

7.  Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis.

Authors:  Eric Torgbenu; Tim Luckett; Mark A Buhagiar; Sungwon Chang; Jane L Phillips
Journal:  BMC Cancer       Date:  2020-06-29       Impact factor: 4.430

Review 8.  Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments.

Authors:  Marco Pappalardo; Marta Starnoni; Gianluca Franceschini; Alessio Baccarani; Giorgio De Santis
Journal:  J Pers Med       Date:  2021-05-12

Review 9.  Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Lin Shui; Sébastien Manirakiza; Louis Ngendahayo
Journal:  East Afr Health Res J       Date:  2019-11-29

10.  The Effect of Acupuncture in Breast Cancer-Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis.

Authors:  Tsai-Ju Chien; Chia-Yu Liu; Ching-Ju Fang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.